Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,351,364
-
Share change
-
+124,952
-
Total reported value
-
$101,086,280
-
Put/Call ratio
-
208%
-
Price per share
-
$42.99
-
Number of holders
-
74
-
Value change
-
+$4,150,942
-
Number of buys
-
36
-
Number of sells
-
22
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2024
As of 31 Dec 2024,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,351,364 shares.
The largest 10 holders included
MORGAN STANLEY, Kingsview Wealth Management, LLC, BANK OF AMERICA CORP /DE/, BNP PARIBAS FINANCIAL MARKETS, LPL Financial LLC, FIRST CITIZENS BANK & TRUST CO, Envestnet Portfolio Solutions, Inc., WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, and JPMORGAN CHASE & CO.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.